The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Clinical trial NCT07064889 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07064889
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-07-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.